Stem cells derived from a patient's bone marrow can help treat severe heart failure, but the results are even better when they are taken from fat, a leading researcher said, citing his experience in a number of studies. "It's no longer a question whether the bone marrow cells work or don't work; they do work when you have healthy stem cells," Dr. James Willerson of the Texas Heart Institute said in an interview. "The search now is to find the very best stem cell type or types.

“Our research shows that reprogramming somatic cells does not require passing through a pluripotent stage,” explains Schöler. “Thanks to this new approach, tissue regeneration is becoming a more streamlined – and safer – process.”

New findings from a transplant study led by scientists from the Diabetes Research Institute at the Miller School and a DRI Federation center at Xiamen University in China showed that mesenchymal stem cells may replace a powerful anti-rejection drug in transplant recipients. The results of this study involving kidney transplant patients, published in the March 21 issue of the Journal of the American Medical Association, may fundamentally transform the future of clinical transplantation.

A joint research team from South Korea and Germany said Friday they have created stem cells that have the potential to help treat people suffering from dementia and spinal cord trauma.

What used to be medical trash is now treating cancer. The University of Virginia's Medical Center is the first place in Virginia to take advantage of stem cells from umbilical cords and they are pleased with the results. Dr. Mary Laughlin, the director of stem cell transplantation at UVA, said, "These are cells that are routinely thrown away, these cells save lives."

Scientists in SA have generated non-embryonic stem cells for the first time, the Council for Scientific and Industrial Research (CSIR) announced on Tuesday.

The California Institute for Regenerative Medicine (CIRM) is about to enter a crucial stage in stem cell research: going to clinical trials. The most promising experiments could cure diabetes, HIV, sickle-cell anemia and blindness in the elderly.

10th Annual Congress of the International Society for Stem Cell Research (ISSCR) was held from 13 to 16 June in Yokohama (Japan).

University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer. To prove the cells' regenerative powers, bone cells grown on this surface were then transplanted into holes in the skulls of mice, producing four times as much new bone growth as in the mice without the extra bone cells.

Researchers at the Hebrew University of Jerusalem have achieved, for the first time, the generation of neuronal cells from stem cells of Fragile X patients. The discovery paves the way for research that will examine restoration of normal gene expression in Fragile X patients.

* Skin reprogrammed into stem cells to try to mend hearts * New heart cells able to integrate with existing tissue * Many years' work ahead before clinical trials could start

A substance in human mesenchymal stem cells that promotes growth appears to spur restoration of nerves and their function in rodent models of multiple sclerosis (MS), researchers at Case Western Reserve University School of Medicine have found.

Two people have had stem cells transplanted into their eyes as part of a clinical trial to restore their sight. The technique has been developed by Scottish specialists to reverse corneal blindness, and it is believed to be the first treatment of its kind in the UK.

Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated that these cells can actually attack HIV-infected cells in a living organism.

A recent study suggests that Mozobil helps multiple myeloma patients with prior exposure to Revlimid collect enough stem cells for transplantation. The study investigators conclude that stem cell mobilization with the aid of a growth factor plus Mozobil (plerixafor) is an effective upfront approach for multiple myeloma patients who plan to undergo a transplant, regardless of previous Revlimid (lenalidomide) exposure.

Researchers at Columbia University Medical Center (CUMC) have identified a molecular pathway that controls the retention and release of the brain's stem cells. The discovery offers new insights into normal and abnormal neurologic development and could eventually lead to regenerative therapies for neurologic disease and injury. The findings, from a collaborative effort of the laboratories of Drs. Anna Lasorella and Antonio Iavarone, were published April 22in the online edition of Nature Cell Biology.

Research group headed by Professor Takashi Tsuji demonstrates regenerating "functional hair regeneration from adult stem cells" Substantial advance in the development of next-generation of "organ replacement regenerative therapies"

Pre-Mother's Day Awareness Campaign Educates Expectant Families on Life-Saving Benefits of Placental Stem Cell and Cord Blood Banking

Combined, complimentary therapies have the ability to maximize the benefits of neural stem cell (NSC) transplantation for spinal cord repair in rat models, according to a study carried out by a team of Korean researchers who published in a recent issue of Cell Transplantation (20:9), now freely available on-line.

Researchers at the University of Colorado School of Medicine have found that lack of a specific gene interrupts neural tube closure, a condition that can cause death or paralysis.

NEXT-GENERATION stem cell therapy has brought scientists a step closer to a treatment for thousands of people with macular degeneration.

The brave new world of stem cell research dangles the exciting potential for a host of leading-edge treatments that may one day help cure debilitating diseases such as Alzheimer's, Parkinson's and other maladies that today cannot be treated with modern medicine.

Researchers at the Children's Hospital of Philadelphia have generated a new type of human stem cell that can develop into numerous types of specialized cells, including functioning pancreatic beta cells that produce insulin.

Stem cells from the pelvic bone may help hearts beat stronger. Doctors and other clinicians at the Orlando Health Heart Institute are researching the use of stem cells from pelvic bone marrow to restore tissue and improve heart function after muscle damage from heart attacks.

Using stem cells from human embryos remains controversial. There’s another wellspring of stem cells that draws virtually no opposition. But this other source often goes to waste.

Doctors have developed a pioneering treatment for liver disease that could save hundreds of lives a year and avoid the need for transplant surgery. Liver specialists desperately need new approaches to the epidemic of liver diseases that is leading to huge demand for donor livers.

Tales from the crypt are supposed to be scary, but new research from Vanderbilt University, the HudsonAlpha Institute for Biotechnology, and colleagues shows that crypts can be places of renewal too: intestinal crypts, that is. Intestinal crypts are small areas of the intestine where new cells are formed to continuously renew the digestive tract. By focusing on one protein expressed in our intestines called Lrig1, the researchers have identified a special population of intestinal stem cells that respond to damage and help to prevent cancer.

A leukemia patient who was twice turned down by a Shanghai stem cell donor recovered from the disease after receiving her mother's half-match stem cells and a unit of umbilical cord blood from Shanghai.

In a great sigh of relief to heart patients, top international researchers here in Hyderabad revealed that Stem Cell Technology can be used to repair damaged heart tissues without actually performing surgical incision into the chest.

A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neuron disease (MND). The international research team has created motor neurons using skin cells from a patient with an inherited form of MND.